Kenvue Inc. Common Stock (KVUE)
16.97
+0.00 (0.00%)
NYSE · Last Trade: Sep 23rd, 4:17 AM EDT
Jim Cramer says Trump creates a "nightmare" for Kenvue after linking Tylenol to autism. Learn why KVUE stock is plunging amid lawsuit fears.
Via Benzinga · September 23, 2025
Guggenheim’s upgrade and new data on J&J’s experimental depression drug helped steady sentiment, even as investors weighed political scrutiny and ongoing litigation risks.
Via Stocktwits · September 23, 2025
U.S. stocks closed higher on Monday, with the Dow Jones Industrial Average edging up 0.14% to 46,381.54.
Via Benzinga · September 22, 2025
Kenvue Stock Hits Record Low As Trump Urges Pregnant Women To ‘Fight Like Hell’ Against Tylenol: Retail Stays Bullishstocktwits.com
Via Stocktwits · September 22, 2025
Kenvue Shares Drop Ahead Of Trump’s ‘Biggest Announcement’ On Autism: Reports Say Administration To Link Tylenol With Risk Of Diseasestocktwits.com
Via Stocktwits · September 22, 2025
Tylenol Maker Kenvue Met With RFK Jr. In A Bid To Keep OTC Painkiller Off Autism List: Reportstocktwits.com
Via Stocktwits · September 12, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.
Via Chartmill · September 22, 2025
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Monday. Discover the stocks that are generating the highest trading volume and driving market activity.
Via Chartmill · September 22, 2025
Wall Street is on track for its third straight day of gains, with major large-cap indices extending records as investors remain optimistic about corporate earnings and upcoming rate cuts.
Via Benzinga · September 22, 2025
Shares of Kenvue Inc (NASDAQ: KVUE) are down Monday in anticipation of a negative Trump administration announcement about one of its products.
Via Benzinga · September 22, 2025
The pharmaceutical landscape is currently a tale of two giants employing vastly different, yet highly successful, growth strategies. Eli Lilly and Company (NYSE: LLY) has placed an extraordinary bet on the burgeoning market for weight-loss and diabetes drugs, driven by its groundbreaking GLP-1 agonists. In stark contrast, Johnson & Johnson (NYSE:
Via MarketMinute · September 22, 2025
Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · September 22, 2025
Monday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Via Chartmill · September 22, 2025
Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top S&P500 gainers and losers in today's pre-market session.
Via Chartmill · September 22, 2025
Trump administration to announce concerns about Tylenol use in pregnancy and potential treatment for autism, in line with President's priority.
Via Benzinga · September 22, 2025
Tylenol is one of the most common medicines for reducing pain and fever, and a major product for Kenvue.
Via Stocktwits · September 22, 2025
Johnson & Johnson (NYSE: JNJ) is navigating a critical juncture in its protracted legal battle over talc-based baby powder. The healthcare behemoth has announced a tentative $700 million settlement with 43 U.S. states and the District of Columbia to resolve allegations of deceptive marketing practices. Simultaneously, the company has put
Via MarketMinute · September 19, 2025
Jim Cramer discussed companies such as Western Union, Johnson Controls, MNTN, Nordic American Tankers, Occidental Petroleum, and Kenvue on CNBC's Mad Money Lightning Round.
Via Benzinga · September 19, 2025
Let's delve into the developments on the US markets one hour before the close of the markets on Monday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Via Chartmill · September 15, 2025
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · September 15, 2025
Kenvue interim CEO Kirk Perry met privately this week with RFK Jr. to argue that there is no proven link between Tylenol and autism.
Via Benzinga · September 12, 2025
Let's have a look at what is happening on the US markets on Monday. Below you can find the most active S&P500 stocks in today's session.
Via Chartmill · September 8, 2025
Evercore said that the recent selloff in shares "might be overdone" when considering the lack of a proven causal link between Tylenol's active ingredient and neurodevelopmental disorders.
Via Stocktwits · September 8, 2025
A softer-than-expected U.S. labor market spooked investors on Friday, dragging major indices lower despite initial optimism over potential Fed rate cuts. Gold surged to record highs as traders sought safety.
Via Chartmill · September 8, 2025